Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Common Equity (2020 - 2025)

Agilon Health's Common Equity history spans 6 years, with the latest figure at $126.7 million for Q4 2025.

  • For Q4 2025, Common Equity fell 73.09% year-over-year to $126.7 million; the TTM value through Dec 2025 reached $126.7 million, down 73.09%, while the annual FY2025 figure was $126.7 million, 73.09% down from the prior year.
  • Common Equity reached $126.7 million in Q4 2025 per AGL's latest filing, down from $306.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.2 billion in Q2 2021 to a low of -$298.2 million in Q1 2021.
  • Average Common Equity over 5 years is $732.9 million, with a median of $780.0 million recorded in 2023.
  • Peak YoY movement for Common Equity: surged 563.3% in 2021, then tumbled 73.09% in 2025.
  • A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then decreased by 4.67% to $1.0 billion in 2022, then crashed by 36.48% to $661.0 million in 2023, then fell by 28.75% to $471.0 million in 2024, then crashed by 73.09% to $126.7 million in 2025.
  • Per Business Quant, the three most recent readings for AGL's Common Equity are $126.7 million (Q4 2025), $306.1 million (Q3 2025), and $408.9 million (Q2 2025).